Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dan Theodorescu

Showing results (151-160 of 275) with videos related to

Pageof 28
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 23, 2015
Loss of Glycogen Debranching Enzyme AGL Drives Bladder Tumor Growth via Induction of Hyaluronic Acid SynthesisSunny Guin, Yuanbin Ru, Neeraj Agarwal, et al.
Cancer Immunology, Immunotherapy : CII|September 17, 2009
Relationship between HLA class I antigen processing machinery component expression and the clinicopathologic characteristics of bladder carcinomasHelen P Cathro, Mark E Smolkin, Dan Theodorescu, et al.
Cancer Research|June 18, 2016
GON4L Drives Cancer Growth through a YY1-Androgen Receptor-CD24 AxisNeeraj Agarwal, Garrett M Dancik, Andrew Goodspeed, et al.
Cancer Research|October 22, 2009
Concordant gene expression signatures predict clinical outcomes of cancer patients undergoing systemic therapyPaul D Williams, Sooyoung Cheon, Dmytro M Havaleshko, et al.
Molecular Cancer Therapeutics|February 20, 2007
Prediction of drug combination chemosensitivity in human bladder cancerDmytro M Havaleshko, HyungJun Cho, Mark Conaway, et al.
Cancer Research|August 17, 2005
Endothelin axis is a target of the lung metastasis suppressor gene RhoGDI2Brian Titus, Henry F Frierson, Mark Conaway, et al.
Journal of Molecular Medicine (Berlin, Germany)|April 1, 2016
High-performance detection of somatic D-loop mutation in urothelial cell carcinoma patients by polymorphism ratio sequencingDavid P Duberow, Mariana Brait, Mohammad O Hoque, et al.
Nature|June 21, 2023
Y chromosome loss in cancer drives growth by evasion of adaptive immunityHany A Abdel-Hafiz, Johanna M Schafer, Xingyu Chen, et al.
Plos One|February 8, 2014
Retrospective analysis of survival improvement by molecular biomarker-based personalized chemotherapy for recurrent ovarian cancerYoungchul Kim, Saketh R Guntupalli, Sun J Lee, et al.
Molecular Cancer Research : MCR|June 17, 2015
Patient Mutation Directed shRNA Screen Uncovers Novel Bladder Tumor Growth SuppressorsJonathan Hensel, Jason E Duex, Charles Owens, et al.
Pageof 28

Showing results (151-160 of 275) with videos related to

Sort By:
Pageof 28
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 23, 2015
Loss of Glycogen Debranching Enzyme AGL Drives Bladder Tumor Growth via Induction of Hyaluronic Acid SynthesisSunny Guin, Yuanbin Ru, Neeraj Agarwal, et al.
Cancer Immunology, Immunotherapy : CII|September 17, 2009
Relationship between HLA class I antigen processing machinery component expression and the clinicopathologic characteristics of bladder carcinomasHelen P Cathro, Mark E Smolkin, Dan Theodorescu, et al.
Cancer Research|June 18, 2016
GON4L Drives Cancer Growth through a YY1-Androgen Receptor-CD24 AxisNeeraj Agarwal, Garrett M Dancik, Andrew Goodspeed, et al.
Cancer Research|October 22, 2009
Concordant gene expression signatures predict clinical outcomes of cancer patients undergoing systemic therapyPaul D Williams, Sooyoung Cheon, Dmytro M Havaleshko, et al.
Molecular Cancer Therapeutics|February 20, 2007
Prediction of drug combination chemosensitivity in human bladder cancerDmytro M Havaleshko, HyungJun Cho, Mark Conaway, et al.
Cancer Research|August 17, 2005
Endothelin axis is a target of the lung metastasis suppressor gene RhoGDI2Brian Titus, Henry F Frierson, Mark Conaway, et al.
Journal of Molecular Medicine (Berlin, Germany)|April 1, 2016
High-performance detection of somatic D-loop mutation in urothelial cell carcinoma patients by polymorphism ratio sequencingDavid P Duberow, Mariana Brait, Mohammad O Hoque, et al.
Nature|June 21, 2023
Y chromosome loss in cancer drives growth by evasion of adaptive immunityHany A Abdel-Hafiz, Johanna M Schafer, Xingyu Chen, et al.
Plos One|February 8, 2014
Retrospective analysis of survival improvement by molecular biomarker-based personalized chemotherapy for recurrent ovarian cancerYoungchul Kim, Saketh R Guntupalli, Sun J Lee, et al.
Molecular Cancer Research : MCR|June 17, 2015
Patient Mutation Directed shRNA Screen Uncovers Novel Bladder Tumor Growth SuppressorsJonathan Hensel, Jason E Duex, Charles Owens, et al.
Pageof 28